Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,798 | -133,813 | -94,151 | -60,022 | -28,525 |
| Depreciation Amortization | -1,369 | -10,255 | -8,282 | -5,644 | -2,625 |
| Accounts payable and accrued liabilities | 2,858 | 1,737 | 1,645 | 2,673 | 780 |
| Other Working Capital | -4,758 | 10,328 | 3,387 | 874 | -2,319 |
| Other Operating Activity | 6,201 | 22,975 | 15,330 | 7,422 | 4,091 |
| Operating Cash Flow | $-37,866 | $-109,028 | $-82,071 | $-54,697 | $-28,598 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -44 | -1,312 | -1,038 | -518 | -297 |
| Purchase Of Investment | 28,942 | -477,055 | -217,260 | -232,181 | -327,603 |
| Sale Of Investment | 15,000 | 293,711 | 12,720 | 1,759 | 59,592 |
| Investing Cash Flow | $43,898 | $-184,656 | $-205,578 | $-230,940 | $-268,308 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,261 | 249,515 | 246,620 | 243,073 | 241,073 |
| Other Financing Activity | -38 | -262 | -262 | -48 | 0 |
| Financing Cash Flow | $2,223 | $249,253 | $246,358 | $243,025 | $241,073 |
| Beginning Cash Position | 41,666 | 86,097 | 86,097 | 86,097 | 86,097 |
| End Cash Position | 49,921 | 41,666 | 44,806 | 43,485 | 30,264 |
| Net Cash Flow | $8,255 | $-44,431 | $-41,291 | $-42,612 | $-55,833 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,866 | -109,028 | -82,071 | -54,697 | -28,598 |
| Capital Expenditure | -44 | -1,312 | -1,038 | -518 | -297 |
| Free Cash Flow | -37,910 | -110,340 | -83,109 | -55,215 | -28,895 |